Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. DrugBank 薬物名(臨床試験情報から抽出) KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Afamelanotide 2件: AFAMELANOTIDE; SCENESSE1件: D10511 1件: MC1R 💬2件: Melanogenesis, Neuroactive ligand-receptor interaction 💬3件: 159, 161, 254
2 Aminolevulinic acid 3件: 5-aminolevulinic acid; Aminolevulinic acid; Gliolan2件: D02908 ,
D07567
--5件: 34, 96, 97, 254, 286
3 Chlorpromazine 2件: Chlorpromazine; Chlorpromazine Hydrochloride4件: D00270 ,
D00789 ,
D03274 ,
D04034
13件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
DRD2,
HRH1,
HTR2A,
HTR2B,
HTR2C 💬
22件: Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 254
4 Cholestyramine 3件: Cholestyramine; COLESTYRAMINE; Questran---3件: 13, 79, 254
5 Cimetidine 1件: Cimetidine2件: D00295 ,
D03503
1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬2件: 2, 254
6 Colestipol 1件: Colestipol2件: D02113 ,
D07771
--1件: 254
7 Cysteine 2件: Cysteine; Cysteine hydrochloride2件: D00026 ,
D02326
--11件: 6, 13, 19, 34, 84, 85, 88, 90, 254, 296, 310
8 Deferasirox 2件: DEFERASIROX; EXJADE1件: D03669 --3件: 254, 284, 286
9 Dextrose, unspecified form 2件: Dextrose; Glucose---19件: 2, 6, 13, 49, 50, 56, 60, 65, 70, 75, 86, 88, 96, 160, 195, 226, 254, 257, 299
10 Givosiran 1件: Givosiran1件: D11702 1件: ALAS1 💬4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬1件: 254
11 Hemin 2件: Hemin; Panhematin1件: D10003 2件: ALAS1,
ALAS2 💬
4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬1件: 254
12 Hydroxychloroquine 3件: Hydroxychloroquine; HYDROXYCHLOROQUINE SULFATE; PLAQUENIL1件: D08050 --27件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299
13 Iron 1件: Iron---6件: 18, 96, 97, 238, 254, 284
14 Isoniazid 1件: Isoniazid3件: D00346 ,
D01501 ,
D02002
--2件: 65, 254
15 Ledipasvir 2件: Harvoni; Ledipasvir1件: D10442 --2件: 19, 254
16 Luteinizing hormone 1件: Luteinizing hormone---1件: 254
17 Porphobilinogen 1件: Porphobilinogen---1件: 254
18 Sofosbuvir 2件: Harvoni; Sofosbuvir1件: D10366 --2件: 19, 254
19 Stannsoporfin 1件: Tin mesoporphyrin1件: D05922 2件: HMOX1,
HMOX2 💬
10件: Chemical carcinogenesis - reactive oxygen species, Ferroptosis, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatocellular carcinoma, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Pathways in cancer, Porphyrin metabolism 💬1件: 254